abstract |
Patients susceptible to suffering from conditions and disorders, such as disorders of the central nervous system, are treated by administering, to a patient suffering from it, aryloxyalkyloamines and arylthioalkyloamines, including pyridyloxyalkyloamines, phenoxyalkylamines, pyridylthioalkyloamines and phenylthioalkyloamines. |